Study of intraoperative dextrose and insulin infusion in liver donor patients
Not Applicable
Completed
- Registration Number
- CTRI/2019/11/021849
- Lead Sponsor
- INDRAPRASTHA APOLLO HOSPITALS
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 174
Inclusion Criteria
ASA GRADE I OR II PATIENTS OF EITHER SEX SCHEDULED FOR RIGHT LOBE DONOR HEPATECTOMY
AGE 18-60 YEARS
Exclusion Criteria
Patient refusal
Patient with uncontrolled blood sugars
Patient with blood loss >1 litre
Patient with remnant liver volume <28 %
Patient with left lobe resection
Patient whose duration of surgery is more than 14 hours
Patient on beta blockers or calcium chanel blockers
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method IVER FUNCTION TESTS ASSESSMENT ON INTRAOPERATIVE ADMINISTRATION OF DEXTROSETimepoint: LIVER FUNCTION TESTS POSTOPERATIVE DAY 7 <br/ ><br>INTRAOPERATIVE LACTATE DIFFERENCE <br/ ><br>
- Secondary Outcome Measures
Name Time Method TO ASSESS RENAL FUNCTION TESTTimepoint: postoperative day 7